Home > Insider Trading > Filing (0001181431-13-062016)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1492426	Horizon Pharma Inc.	HZNP	Pharmaceutical Preparations (2834)	272179987

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1349376	P Timothy Walbert	C/O Horizon Pharma, Inc. 520 Lake Cook Road, Suite 520 Deerfield IL 60015	President, Chairman And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-12-05	43,290	$0.00	127,411	No	4	A	Direct
Common Stock	Acquisiton	2013-12-09	33,210	$0.00	160,621	No	4	M	Direct
Common Stock	Disposition	2013-12-09	12,124	$6.79	148,497	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted stock units	Disposition	2013-12-09	33,210	$0.00	99,631	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
66,421			No	4	M	Direct

Footnotes

Fully vested deferred issuance of restricted stock units provided as a one-time bonus payment in connection with the completion of the Company's acquisition of U.S. rights to VIMOVO (R).
Includes 5,460 shares of the Company's common stock acquired in June 2013 pursuant to an employee stock purchase program.
Reflects shares of common stock surrendered via open market sale to satisfy tax withholding obligations in connection with vesting of restricted stock units.
Each restricted stock units represents a contingent right to receive one share of Horizon Pharma, Inc. common stock.
On December 8, 2011, the reporting person was granted 132,842 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.